Moleculin Biotech ( NASDAQ: MBRX ) announced the pricing of a public offering of about 2.5M shares of its common stock, Series A warrants to purchase up to 2.5M shares of common stock and Series B warrants to purchase up to 2.
5M shares of common stock, at a combined price of $2.23 per share and accompanying warrants. The gross proceeds from the offering are expected to be approximately $5.
5M and up to an additional approximately $11M in gross proceeds if the warrants are fully exercised for cash. Source: Press Release More on Moleculin Biotech Moleculin Biotech GAAP EPS of -$1.70 beats by $0.
74 Seeking Alpha’s Quant Rating on Moleculin Biotech Historical earnings data for Moleculin Biotech Financial information for Moleculin Biotech.